融捷健康
(300247)
| 流通市值：30.55亿 | | | 总市值：30.55亿 |
| 流通股本：8.04亿 | | | 总股本：8.04亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 395,399,215.15 | 239,862,774.58 | 933,150,483.42 | 651,895,498.63 |
| 营业总成本 | 315,625,272.98 | 193,769,700.01 | 785,062,079.82 | 537,277,453.11 |
| 其他经营收益 | | | | |
| 营业利润 | 97,112,001.67 | 49,782,476.3 | 145,394,327.09 | 119,018,793.24 |
| 利润总额 | 97,843,244.86 | 49,975,397.52 | 147,932,163.34 | 119,978,688.5 |
| 净利润 | 64,465,957.95 | 36,430,717.97 | 108,145,094.75 | 91,494,163.14 |
| 每股收益 | | | | |
| 其他综合收益 | -10,512,768.93 | -5,105,313.61 | -3,565,380.06 | -3,779,607.86 |
| 综合收益总额 | 53,953,189.02 | 31,325,404.36 | 104,579,714.69 | 87,714,555.28 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,134,208,303.54 | 1,086,374,188.4 | 1,087,430,673.09 | 1,037,094,250.29 |
| 非流动资产: | | | | |
| 非流动资产合计 | 416,254,984.28 | 422,452,180.7 | 427,616,718.54 | 446,529,442.99 |
| 资产总计 | 1,550,463,287.82 | 1,508,826,369.1 | 1,515,047,391.63 | 1,483,623,693.28 |
| 流动负债: | | | | |
| 流动负债合计 | 159,421,970.05 | 135,507,840.67 | 167,437,419.73 | 149,585,486.79 |
| 非流动负债: | | | | |
| 非流动负债合计 | 90,684,576.98 | 95,589,572.3 | 101,206,420.13 | 104,499,814.12 |
| 负债合计 | 250,106,547.03 | 231,097,412.97 | 268,643,839.86 | 254,085,300.91 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,175,556,569.08 | 1,156,806,175.91 | 1,138,176,264.66 | 1,129,764,250.16 |
| 股东权益合计 | 1,300,356,740.79 | 1,277,728,956.13 | 1,246,403,551.77 | 1,229,538,392.37 |
| 负债和股东权益合计 | 1,550,463,287.82 | 1,508,826,369.1 | 1,515,047,391.63 | 1,483,623,693.28 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 498,832,377.26 | 294,074,881.46 | 976,934,726.27 | 652,982,438.87 |
| 经营活动现金流出小计 | 481,483,444.25 | 258,427,652.07 | 861,218,584.83 | 610,717,775.86 |
| 经营活动产生的现金流量净额 | 17,348,933.01 | 35,647,229.39 | 115,716,141.44 | 42,264,663.01 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 448,606,686.18 | 312,443,973.68 | 325,291,395.88 | 587,218,940.13 |
| 投资活动现金流出小计 | 393,811,502.32 | 269,313,331.41 | 334,278,395.87 | 611,229,700.81 |
| 投资活动产生的现金流量净额 | 54,795,183.86 | 43,130,642.27 | -8,986,999.99 | -24,010,760.68 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 7,888,421.39 | - | 11,132,887.02 | 8,609,201.54 |
| 筹资活动产生的现金流量净额 | -7,888,421.39 | - | -11,132,887.02 | -8,609,201.54 |
| 汇率变动对现金及现金等价物的影响 | -8,282,580.77 | -4,420,616.24 | -7,900,101.42 | -2,372,546.92 |
| 现金及现金等价物净增加额 | 55,973,114.71 | 74,357,255.42 | 87,696,153.01 | 7,272,153.87 |
| 期末现金及现金等价物余额 | 323,992,802.13 | 342,376,942.84 | 268,019,687.42 | 187,595,688.28 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 55,973,114.71 | - | 87,696,153.01 | - |